BRPI0822637A2 - Uso de lanosta-8, 24-dien-3-óis - Google Patents

Uso de lanosta-8, 24-dien-3-óis

Info

Publication number
BRPI0822637A2
BRPI0822637A2 BRPI0822637-7A BRPI0822637A BRPI0822637A2 BR PI0822637 A2 BRPI0822637 A2 BR PI0822637A2 BR PI0822637 A BRPI0822637 A BR PI0822637A BR PI0822637 A2 BRPI0822637 A2 BR PI0822637A2
Authority
BR
Brazil
Prior art keywords
lanosta
dien
Prior art date
Application number
BRPI0822637-7A
Other languages
English (en)
Inventor
Luiz Francisco Pianowski
João Calixto Batista
Paulo César Leal
Claudio Paulino Chaves
Original Assignee
Amazônia Fitomedicamentos Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amazônia Fitomedicamentos Ltda filed Critical Amazônia Fitomedicamentos Ltda
Publication of BRPI0822637A2 publication Critical patent/BRPI0822637A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
BRPI0822637-7A 2008-08-05 2008-08-05 Uso de lanosta-8, 24-dien-3-óis BRPI0822637A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2008/002051 WO2010015874A1 (en) 2008-08-05 2008-08-05 Pharmaceutical uses of lanosta-8,24-dien-3-ols

Publications (1)

Publication Number Publication Date
BRPI0822637A2 true BRPI0822637A2 (pt) 2015-06-16

Family

ID=40210741

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0822637-7A BRPI0822637A2 (pt) 2008-08-05 2008-08-05 Uso de lanosta-8, 24-dien-3-óis

Country Status (17)

Country Link
US (1) US9238036B2 (pt)
EP (1) EP2323666B1 (pt)
JP (1) JP5579181B2 (pt)
KR (1) KR101496507B1 (pt)
CN (1) CN102112133B (pt)
AU (1) AU2008360329B2 (pt)
BR (1) BRPI0822637A2 (pt)
CA (1) CA2732850C (pt)
DK (1) DK2323666T3 (pt)
ES (1) ES2619505T3 (pt)
IL (1) IL211062A (pt)
MX (1) MX2011001411A (pt)
NZ (1) NZ590233A (pt)
PT (1) PT2323666T (pt)
RU (1) RU2476226C2 (pt)
WO (1) WO2010015874A1 (pt)
ZA (1) ZA201100119B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011086424A1 (en) * 2010-01-15 2011-07-21 Amazonia Fitomedicamentos Ltda Pharmaceutical use of multicyclic compounds mixtures as concomitant anti-cancer, anti-inflammatory and anti-pain agents
US20130332421A1 (en) * 2012-06-06 2013-12-12 International Business Machines Corporation Defining Content Retention Rules Using a Domain-Specific Language
CA2958868A1 (en) * 2014-08-22 2016-02-25 Guangzhou Kangrui Biological Pharmaceutical Technology Co., Ltd. Compositions and methods to treat vision disorders
CN109364020B (zh) * 2015-09-02 2021-12-28 盛世泰科生物医药技术(苏州)有限公司 一种用于预防和治疗白内障的眼用制剂及其制备方法
JP2025504209A (ja) * 2022-02-07 2025-02-06 リヴフル インコーポレイテッド がん、炎症および疼痛治療のためのバイオアベイラビリティを向上させた新規トリテルペンアルコール誘導体の調製

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR179F (pt) * 1963-09-12
US3625954A (en) * 1968-03-20 1971-12-07 Pfizer 1-aroylbenzimidazoles
DE10155200A1 (de) * 2001-11-12 2003-05-28 Skinlab Gmbh Verwendung von Cholesterin, cholesterinhaltigen Substanzen oder von den Cholesteringehalt erhöhenden Substanzen in kosmetischen und dermatologischen Zubereitungen zum Zwecke der UV-Protektion
WO2006007676A1 (en) * 2004-07-21 2006-01-26 Amazônia Fitomedicamentos Ltda. Combination of active fractions from the plants euphorbia tirucalli l and ficos carica l. and method of treating cancer and aids

Also Published As

Publication number Publication date
CA2732850A1 (en) 2010-02-11
IL211062A (en) 2015-02-26
JP5579181B2 (ja) 2014-08-27
IL211062A0 (en) 2011-04-28
CA2732850C (en) 2016-06-21
AU2008360329A2 (en) 2011-06-16
PT2323666T (pt) 2017-04-06
EP2323666B1 (en) 2017-01-04
ES2619505T3 (es) 2017-06-26
ZA201100119B (en) 2012-03-28
EP2323666A1 (en) 2011-05-25
MX2011001411A (es) 2011-03-15
AU2008360329A1 (en) 2010-02-11
US9238036B2 (en) 2016-01-19
US20110136773A1 (en) 2011-06-09
CN102112133A (zh) 2011-06-29
KR20110044984A (ko) 2011-05-03
RU2011108558A (ru) 2012-09-10
DK2323666T3 (en) 2017-04-10
RU2476226C2 (ru) 2013-02-27
JP2011529956A (ja) 2011-12-15
NZ590233A (en) 2012-10-26
AU2008360329B2 (en) 2014-07-31
KR101496507B1 (ko) 2015-03-03
CN102112133B (zh) 2013-05-08
WO2010015874A1 (en) 2010-02-11

Similar Documents

Publication Publication Date Title
BR112012002349A2 (pt) composto,e, uso do mesmo
NO2021006I1 (no) Quofenix, delafloksacin
BRPI0821668A2 (pt) Uso
BRPI1012533A2 (pt) composto de piradazinona e uso do mesmo
BRPI0915134A2 (pt) composto, e, uso de um composto
BRPI0823082A2 (pt) Uso derivados de sesquiterpeno
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0921327A2 (pt) Combinação de herbicida-protetor
BRPI0911695A2 (pt) conjunto de barbear
BRPI0921389A2 (pt) seringa de um só uso, de inutilização automática
BRPI0907376A2 (pt) Fotobiorretador
BRPI0915086A2 (pt) detecção do uso de canabis
FIC20240018I1 (fi) Vamoroloni
BRPI0914649A2 (pt) Piprazolo-quinazolinas
BRPI0915064A2 (pt) derivados de qunoxalinadiona
BRPI0913832A2 (pt) derivados de pirrolopiridinilpirimidin-2-ilamina
DE112009000578A5 (de) Reibahle
BRPI1006996A2 (pt) composição, método e uso
BRPI0922652A2 (pt) Derivados de quinazolinamida
BRPI0907522A2 (pt) biarlamidas
BRPI0913234A2 (pt) derivados de tiazolilpiperidina
BRPI1011036A2 (pt) uso
BRPI0913267A2 (pt) uso do ácido succínico
BRPI0909634A2 (pt) 2-aminoquinolinas
BRPI0920833A2 (pt) preparação de benzonorborbenos

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]